Story at a glance
- Moderna officials announced it will deliver more than 30 million doses of its COVID-19 vaccine to the U.S.
- Although the company has provided about 45.4 million vaccine doses, just 25.5 million have been administered so far.
COVID-19 vaccine manufacturer Moderna said that it will be providing an additional 33.2 million doses of its vaccine to the U.S. government for distribution.
Announced in a press release, the pharmaceutical company confirmed it had already supplied the U.S. with about 45.4 million doses to date, with around 25.5 million having been administered based on U.S. Centers for Disease Control and Prevention (CDC) data.
As Moderna finishes filling its vials — with more amounts of the vaccine per vial — delays may occur, but they are not anticipated to affect monthly deliverable targets.
Per the deal made with the federal government, Moderna anticipates to finish delivering 100 million doses by the end of March, followed by 100 million additional doses by the end of May 2021, followed by another 100 million doses by the end of July.
“The [Moderna] does not intend to stockpile significant quantities to smooth shipments, choosing instead to ship doses to the U.S. Government as released,” the statement said. “The Company is in active and frequent communication with the U.S. Government to provide transparency on expected timing of deliveries in order to aid the U.S. Government’s vaccine deployment efforts.”
This comes as President Biden announced on Twitter that he expects to surpass his goal of vaccinating 100 million Americans in the first 100 days of his presidency.
Before I took office, I set a big goal of administering 100 million shots in the first 100 days. With the progress we’re making I believe we’ll not only reach that, we’ll break it.— President Biden (@POTUS) February 16, 2021
New COVID-19 cases have dwindled steadily since hitting an all-time high in mid-January following crowded holiday gatherings across the country. National data reports a 43 percent decline in cases, along with drops in associated hospitalizations and fatalities.